Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine Phosphate Prophylaxis for COVID-19 in Healthcare Workers
NCT04443270Phase 1Unknown
- Sponsor
- Centro Médico Nacional 20 de Noviembre
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of chloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Centro Médico Nacional 20 de Noviembre. Primary endpoints: Negative Polymerase Chain Reaction assay at day 0 and Polymerase Chain Reaction assay at day 60. Status: unknown.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04443270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443270.